Diphenyl Diselenide Helps Diabetic Kidney Disease by Changing Gut Bacteria
Author Information
Author(s): Wang Xing, Long Dongmei, Peng Xingcan, Li Jiaxuan, Zhou Maoting, Wang Yu, Hu Xianghong
Primary Institution: North Sichuan Medical College
Hypothesis
Does diphenyl diselenide alleviate diabetic kidney disease by inhibiting extracellular matrix production and regulating gut microbiota?
Conclusion
Diphenyl diselenide improves kidney function in diabetic rats by reducing oxidative stress and restoring gut microbiota balance.
Supporting Evidence
- Diphenyl diselenide reduced blood glucose and improved kidney function in diabetic rats.
- It decreased the levels of harmful proteins in the kidneys.
- DPDS improved the diversity of gut bacteria in diabetic rats.
- Oxidative stress markers were significantly reduced with DPDS treatment.
- DPDS treatment led to a decrease in extracellular matrix production in the kidneys.
Takeaway
This study shows that a compound called diphenyl diselenide can help protect the kidneys in diabetic rats by fixing the bacteria in their guts and reducing stress in their bodies.
Methodology
Rats were treated with diphenyl diselenide or metformin for eight weeks, and various kidney and gut health indicators were measured.
Limitations
The study did not analyze specific metabolites of gut bacteria or confirm the role of diphenyl diselenide in renal fibrosis using advanced staining techniques.
Participant Demographics
Fifty male Sprague-Dawley rats aged 6-7 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website